4.7 Article

SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen

Journal

JOURNAL OF MEDICAL VIROLOGY
Volume 93, Issue 2, Pages 892-898

Publisher

WILEY
DOI: 10.1002/jmv.26320

Keywords

antibody-dependent enhancement; COVID-19; receptor-binding domain; S1; SARS-CoV-2 subunit vaccine; spike protein

Categories

Funding

  1. CAMS Initiative for Innovative Medicine [2017-I2M-3-022]
  2. National Natural Science Foundation of China [81503117]

Ask authors/readers for more resources

The S1 domain of SARS-CoV-2 induces higher levels of antibodies in mice and efficiently neutralizes the virus when adjuvanted with alum. Research suggests that expression systems with posttranslational modification abilities and adjuvants prone to a Th1 response are crucial for effective COVID-19 vaccines.
Since its emergence in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into a global pandemic within a matter of months. While subunit vaccines are one of the prominent options for combating coronavirus disease 2019 (COVID-19), the immunogenicity of spike protein-based antigens remains unknown. When immunized in mice, the S1 domain induced much higher IgG and IgA antibody levels than the receptor-binding domain (RBD) and more efficiently neutralized SARS-CoV-2 when adjuvanted with alum. It is inferred that a large proportion of these neutralization epitopes are located in the S1 domain but outside the RBD and that some of these are spatial epitopes. This finding indicates that expression systems with posttranslational modification abilities are important to maintain the natural configurations of recombinant spike protein antigens and are critical for effective COVID-19 vaccines. Further, adjuvants prone to a Th1 response should be considered for S1-based subunit COVID-19 vaccines to reduce the potential risk of antibody-dependent enhancement of infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available